Log In
BCIQ
Print this Print this
 

cebranopadol (GRT6005)

  Manage Alerts
Collapse Summary General Information
Company Gruenenthal Group
DescriptionPrepronociceptin (PNOC; NOP) and opioid receptor (OPR) agonist
Molecular Target Prepronociceptin (PNOC) (NOP) ; Opioid receptor (OPR)
Mechanism of ActionOpioid receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat chronic lower back pain; Treat chronic nociceptive pain; Treat moderate to severe chronic cancer pain; Treat moderate to severe pain due to osteoarthritis of the knee; Treat neuropathic pain
Regulatory Designation
PartnerDepomed Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$25.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/17/2015

Undisclosed

$25.0M

Undisclosed

Get a free BioCentury trial today